ETrade Capital Management’s CryoPort CYRX Stock Holding History

ETrade Capital Management’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,317	Closed	-$221K	–	899
2020 Q2	$221K	Buy	+7,317	New	+$163K	﹤0.01%	746

Other funds holding CYRX

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ETrade Capital Management's CYRX Position: Q3 2020 in Review

ETrade Capital Management sold out of CryoPort (CYRX) in Q3 2020, closing a stake of 7,317 shares — an estimated $221K sold.

ETrade Capital Management first reported a position in CYRX in Q2 2020 and held it in 1 quarter. The position peaked at $221K in Q2 2020. 171 funds tracked by Wall St. Rank hold CYRX as of Q3 2020.

ETrade Capital Management reported no remaining CryoPort position as of Q3 2020 after selling out during the quarter.
ETrade Capital Management sold 7,317 CryoPort shares in Q3 2020, an estimated $221K.
ETrade Capital Management first reported a position in CryoPort in Q2 2020 and held it in 1 quarter.
ETrade Capital Management's CryoPort position peaked at $221K in Q2 2020.
171 funds tracked by Wall St. Rank held CryoPort as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.